About Ted Meadows
Ted Meadows joined Beasley Allen in 2001 and has since secured over $1.4 billion in verdicts and settlements. He is a key leader of talc litigation nationally, having helped Beasley Allen become co-lead counsel in the national talcum powder/ovarian cancer MDL and driving significant verdicts that spurred changes in the cosmetics industry. Ted is a member of the American Association for Justice, co-chaired several AAJ Section Steering Committees, and is a fellow of the Litigation Counsel of America. He earned his B.S. in Corporate Finance from the University of Alabama in 1988 and his J.D. from Cumberland School of Law in 1991.
Proven verdicts and settlements at Beasley Allen
These results are credited to Beasley Allen. A result appears under an attorney's own name only when a published source names them as counsel on the case.
As chair of the plaintiffs' negotiating committee and Liaison Counsel in the Vioxx multidistrict litigation, Russ Herman directed the negotiations that produced a $4.85 billion settlement with Merck resolving approximately 45,000 to 50,000 personal-injury claims.
Monsanto and its chemical spinoff Solutia agreed in August 2003 to pay $700 million to resolve claims from more than 21,000 Anniston, Alabama residents who were exposed to polychlorinated biphenyls the company manufactured and dumped near their homes for nearly four decades.
San Francisco Unified School District's case was the first JUUL bellwether trial against Altria; after the plaintiffs rested, Altria agreed to pay $235 million to resolve roughly 6,000 pending e-vapor claims nationwide.
Beasley Allen, representing Alabama on contingency, secured $220 million from opioid distributors Cardinal Health and Cencora after roughly 18 months of litigation, with every dollar directed to statewide opioid abatement programs.
Prior results do not guarantee a similar outcome. Each case is unique and depends on its own facts.
Practice areas
Education
Bar admissions & credentials
Other attorneys at Beasley Allen
View firm →
